Go, Epifania C.
HRN: 00-02-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/22/2024
06/22/2024
IV
4.5 Gm
Initial Dose
Cellulitis, Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes